News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
285,160 Results
Type
Article (9274)
Company Profile (125)
Press Release (275761)
Multimedia
Podcasts (18)
Webinars (6)
Section
Business (85564)
Career Advice (271)
Deals (14748)
Drug Delivery (34)
Drug Development (26957)
Employer Resources (56)
FDA (8066)
Job Trends (7369)
News (137895)
Policy (11368)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (4)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (1169)
Accelerated approval (1)
Adcomms (1)
Allergies (38)
Alliances (26533)
ALS (44)
Alzheimer's disease (606)
Antibody-drug conjugate (ADC) (66)
Approvals (8169)
Artificial intelligence (182)
Autoimmune disease (7)
Automation (12)
Bankruptcy (79)
Best Places to Work (6693)
BIOSECURE Act (10)
Biosimilars (44)
Biotechnology (80)
Bladder cancer (35)
Brain cancer (17)
Breast cancer (144)
Cancer (1195)
Cardiovascular disease (88)
Career advice (243)
Career pathing (8)
CAR-T (76)
Cell therapy (227)
Cervical cancer (14)
Clinical research (23305)
Collaboration (614)
Compensation (130)
Complete response letters (5)
COVID-19 (713)
CRISPR (21)
C-suite (169)
Cystic fibrosis (39)
Data (1176)
Denatured (13)
Depression (19)
Diabetes (118)
Diagnostics (3229)
Digital health (11)
Diversity (1)
Diversity, equity & inclusion (20)
Drug discovery (68)
Drug pricing (39)
Drug shortages (3)
Duchenne muscular dystrophy (44)
Earnings (27968)
Editorial (7)
Employer branding (4)
Employer resources (49)
Events (43973)
Executive appointments (511)
FDA (8854)
Featured Employer (39)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (519)
Gene editing (46)
Generative AI (14)
Gene therapy (144)
GLP-1 (220)
Government (1365)
Grass and pollen (1)
Guidances (27)
Healthcare (9103)
Huntington's disease (4)
IgA nephropathy (13)
Immunology and inflammation (39)
Indications (24)
Infectious disease (781)
Inflammatory bowel disease (64)
Inflation Reduction Act (6)
Influenza (28)
Intellectual property (63)
Interviews (37)
IPO (6238)
IRA (21)
Job creations (1058)
Job search strategy (215)
Kidney cancer (4)
Labor market (9)
Layoffs (108)
Leadership (5)
Legal (1954)
Liver cancer (33)
Lung cancer (172)
Lymphoma (71)
Machine learning (3)
Management (17)
Manufacturing (185)
MASH (18)
Medical device (8788)
Medtech (8790)
Mergers & acquisitions (8906)
Metabolic disorders (240)
Multiple sclerosis (30)
NASH (1)
Neurodegenerative disease (31)
Neuropsychiatric disorders (6)
Neuroscience (854)
NextGen: Class of 2025 (2869)
Non-profit (2311)
Northern California (1077)
Now hiring (3)
Obesity (103)
Opinion (97)
Ovarian cancer (40)
Pain (47)
Pancreatic cancer (42)
Parkinson's disease (79)
Partnered (14)
Patents (132)
Patient recruitment (67)
Peanut (20)
People (26822)
Pharmaceutical (35)
Pharmacy benefit managers (1)
Phase I (6733)
Phase II (9361)
Phase III (8808)
Pipeline (581)
Policy (55)
Postmarket research (819)
Preclinical (2211)
Press Release (48)
Prostate cancer (63)
Psychedelics (4)
Radiopharmaceuticals (266)
Rare diseases (162)
Real estate (2672)
Recruiting (22)
Regulatory (9019)
Reports (20)
Research institute (1182)
Resumes & cover letters (30)
Rett syndrome (2)
RSV (10)
Schizophrenia (33)
Series A (90)
Series B (61)
Service/supplier (8)
Sickle cell disease (22)
Southern California (1015)
Special edition (2)
Spinal muscular atrophy (48)
Sponsored (11)
Startups (1809)
State (1)
Stomach cancer (3)
Supply chain (35)
Tariffs (10)
The Weekly (4)
United States (11639)
Vaccines (209)
Venture capitalists (19)
Weight loss (46)
Women's health (19)
Worklife (7)
Date
Today (45)
Last 7 days (289)
Last 30 days (1312)
Last 365 days (18553)
2025 (5504)
2024 (19394)
2023 (20499)
2022 (25072)
2021 (26214)
2020 (24916)
2019 (23631)
2018 (17807)
2017 (15435)
2016 (14372)
2015 (15848)
2014 (11103)
2013 (9012)
2012 (9669)
2011 (9364)
2010 (7900)
Location
Africa (239)
Alabama (24)
Alaska (4)
Arizona (78)
Arkansas (11)
Asia (19467)
Australia (2477)
California (2673)
Canada (1084)
China (407)
Colorado (140)
Connecticut (169)
Delaware (81)
Europe (44676)
Florida (489)
Georgia (127)
Idaho (26)
Illinois (332)
India (15)
Indiana (231)
Iowa (9)
Japan (106)
Kansas (49)
Kentucky (9)
Louisiana (5)
Maine (27)
Maryland (450)
Massachusetts (2151)
Michigan (118)
Minnesota (224)
Mississippi (1)
Missouri (60)
Montana (23)
Nebraska (12)
Nevada (40)
New Hampshire (43)
New Jersey (1046)
New Mexico (19)
New York (917)
North Carolina (547)
North Dakota (6)
Northern California (1077)
Ohio (116)
Oklahoma (11)
Oregon (19)
Pennsylvania (705)
Puerto Rico (5)
Rhode Island (23)
South America (363)
South Carolina (18)
South Dakota (1)
Southern California (1015)
Tennessee (73)
Texas (453)
Utah (91)
Virginia (76)
Washington D.C. (33)
Washington State (229)
West Virginia (1)
Wisconsin (51)
285,160 Results for "isologic innovative radiopharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Radiopharmaceuticals
5 Big Pharmas Push Boundaries in Radiopharmaceuticals
While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their radiopharmaceutical assets to a market projected to be worth over $13 billion by 2033.
March 31, 2025
·
9 min read
·
Tristan Manalac
Press Releases
PharmaLogic to Acquire Majority Stake in Agilera, Strengthening Global Expertise in Radiopharmaceutical Therapeutics
April 10, 2025
·
5 min read
Press Releases
Mirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software
April 2, 2025
·
3 min read
Press Releases
Curium Further Expands European Availability of PYLCLARI – an Innovative 18F-PSMA PET Radiopharmaceutical Indicated in Patients with Prostate Cancer
January 28, 2025
·
2 min read
Genetown
Aktis Oncology to Participate in TD Cowen’s 2nd Annual Radiopharmaceutical Innovation Summit
Aktis Oncology, a clinical biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, announced that Matthew Roden, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the TD Cowen 2nd Annual Radiopharmaceutical Innovation Summit on Monday, June 17, 2024 at 9:20 a.m. ET.
June 10, 2024
·
1 min read
Isologic Launches Illuccix® PSMA PET Imaging Agent to Detect Prostate Cancer
Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix®, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada.
March 16, 2023
·
2 min read
Press Releases
National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma
March 31, 2025
·
10 min read
Press Releases
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
March 31, 2025
·
4 min read
Press Releases
Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies
January 22, 2025
·
4 min read
Press Releases
TwoStep Therapeutics Unveils Its Lead Tumor-Targeted Drug Conjugate and New Radiopharmaceutical Program at Debut Scientific Presentation
March 19, 2025
·
1 min read
1 of 28,516
Next
